Transcriptional	O
regulation	O
of	O
lysosomal	B-protein
acid	I-protein
lipase	I-protein
in	O
differentiating	O
monocytes	O
is	O
mediated	O
by	O
transcription	B-protein
factors	I-protein
Sp1	B-protein
and	O
AP-2	B-protein
.	O

Human	O
lysosomal	B-protein
acid	I-protein
lipase	I-protein
(	O
LAL	B-protein
)	O
is	O
a	O
hydrolase	B-protein
required	O
for	O
the	O
cleavage	O
of	O
cholesteryl	O
esters	O
and	O
triglycerides	O
derived	O
from	O
plasma	O
lipoproteins	O
.	O

It	O
is	O
shown	O
here	O
that	O
during	O
monocyte	O
to	O
macrophage	O
differentiation	O
,	O
the	O
expression	O
of	O
LAL-mRNA	B-RNA
is	O
induced	O
.	O

This	O
induction	O
is	O
dependent	O
on	O
protein	B-protein
kinase	I-protein
C	I-protein
activity	O
and	O
protein	O
synthesis	O
.	O

The	O
cell	O
type-specific	O
increase	O
in	O
LAL	B-protein
expression	O
is	O
further	O
investigated	O
in	O
the	O
THP-1	B-cell_line
cell	I-cell_line
line	I-cell_line
with	O
respect	O
to	O
transcriptional	O
regulation	O
.	O

The	O
human	B-cell_line
monocytic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	B-cell_line
differentiates	O
into	O
macrophage-like	B-cell_type
cells	I-cell_type
when	O
treated	O
with	O
phorbol	O
esters	O
.	O

In	O
order	O
to	O
determine	O
the	O
cis-acting	B-DNA
elements	I-DNA
necessary	O
for	O
both	O
basal	O
and	O
phorbol	O
12-myristate-13	O
acetate	O
(	O
PMA	O
)	O
-enhanced	O
promoter	O
activity	O
,	O
we	O
performed	O
deletion	O
analysis	O
and	O
reporter	B-DNA
gene	I-DNA
assays	O
.	O

A	O
PMA	B-DNA
responsive	I-DNA
element	I-DNA
has	O
been	O
identified	O
between	O
-182	B-DNA
bp	I-DNA
and	O
-107	B-DNA
bp	I-DNA
upstream	O
of	O
the	O
major	B-DNA
transcription	I-DNA
start	I-DNA
site	I-DNA
.	O

Gel	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
binding	O
of	O
Sp1	B-protein
and	O
AP-2	B-protein
to	O
the	O
LAL	B-DNA
promoter	I-DNA
is	O
increased	O
by	O
PMA	O
in	O
THP-1	B-cell_line
cells	I-cell_line
.	O

Co-transfections	O
with	O
expression	B-DNA
plasmids	I-DNA
for	O
Sp1	B-protein
and	O
AP-2	B-protein
further	O
emphasized	O
the	O
important	O
role	O
of	O
these	O
transcription	B-protein
factors	I-protein
in	O
both	O
basal	O
and	O
PMA-enhanced	O
LAL	B-protein
expression	O
.	O

Our	O
data	O
suggest	O
that	O
differentiation	O
dependent	O
increase	O
of	O
lysosomal	B-protein
acid	I-protein
lipase	I-protein
(	O
LAL	B-protein
)	O
expression	O
in	O
THP-1	B-cell_line
cells	I-cell_line
is	O
mediated	O
by	O
a	O
concerted	O
action	O
of	O
Sp1	B-protein
and	O
AP-2	B-protein
.	O

ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
in	NULL
differentiating	NULL
monocytes	NULL
is	NULL
mediated	NULL
by	NULL
transcription	NULL
factors	NULL
Sp1	NULL
and	NULL
AP	NULL
-2	NULL
Stefan	NULL
Ries	NULL
,	NULL
Christa	NULL
Biichler	NULL
,	NULL
Thomas	NULL
Langmann	NULL
,	NULL
Petra	NULL
Fehringer	NULL
,	NULL
Charalampos	NULL
Aslanidis	NULL
,	NULL
and	NULL
Gerd	NULL
Schmitz	NULL
)	NULL
Institute	NULL
for	NULL
Clinical	NULL
Chemistry	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Regensburg	NULL
,	NULL
D-93042	NULL
Regensburg	NULL
,	NULL
Germany	NULL
Abstract	NULL
Human	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
(	NULL
LAL	NULL
)	NULL
is	NULL
a	NULL
hydrolase	NULL
required	NULL
for	NULL
the	NULL
cleavage	NULL
of	NULL
cholesteryl	NULL
esters	NULL
and	NULL
triglycerides	NULL
derived	NULL
from	NULL
plasma	NULL
lipoproteins	NULL
.	NULL

It	NULL
is	NULL
shown	NULL
here	NULL
that	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
LAL-mRNA	NULL
is	NULL
induced	NULL
.	NULL

This	NULL
induction	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL

The	NULL
cell	NULL
type-specific	NULL
increase	NULL
in	NULL
LAL	NULL
expression	NULL
is	NULL
further	NULL
investigated	NULL
in	NULL
the	NULL
THP	NULL
cell	NULL
line	NULL
with	NULL
respect	NULL
to	NULL
transcriptional	NULL
regulation	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
differentiates	NULL
into	NULL
macrophage-like	NULL
cells	NULL
when	NULL
treated	NULL
with	NULL
phorbol	NULL
esters	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
cis-acting	NULL
elements	NULL
necessary	NULL
for	NULL
both	NULL
basal	NULL
and	NULL
phorbol	NULL
12-myristate-13	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
-enhanced	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
performed	NULL
deletion	NULL
analysis	NULL
and	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

A	NULL
PMA	NULL
responsive	NULL
element	NULL
has	NULL
been	NULL
identified	NULL
between	NULL
-182	NULL
bp	NULL
and	NULL
-107	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
binding	NULL
of	NULL
Sp1	NULL
and	NULL
AP-2	NULL
to	NULL
the	NULL
LAL	NULL
promoter	NULL
is	NULL
increased	NULL
by	NULL
PMA	NULL
in	NULL
THP	NULL
cells	NULL
.	NULL

Co-transfections	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
Sp1	NULL
and	NULL
AP-2	NULL
further	NULL
emphasized	NULL
the	NULL
important	NULL
role	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
both	NULL
basal	NULL
and	NULL
PMA-enhanced	NULL
LAL	NULL
expression.8§	NULL
Our	NULL
data	NULL
suggest	NULL
that	NULL
differentiation	NULL
dependent	NULL
increase	NULL
of	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
(	NULL
LAL	NULL
)	NULL
expression	NULL
in	NULL
THP	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
concerted	NULL
action	NULL
of	NULL
Sp1	NULL
and	NULL
AP-2.-Ries	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Biichler	NULL
,	NULL
T.	NULL
Langmann	NULL
,	NULL
P.	NULL
Fehringer	NULL
,	NULL
C.	NULL
Aslanidis	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
in	NULL
differentiating	NULL
monocytes	NULL
is	NULL
mediated	NULL
by	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

J	NULL
Lipid	NULL
Res	NULL
.	NULL

1998	NULL
.	NULL

39	NULL
:	NULL
2125-2134	NULL
.	NULL

Supplementary	NULL
key	NULL
words	NULL
-	NULL
cholesterol	NULL
metabolism	NULL
«	NULL
acid	NULL
lipase	NULL
»	NULL
lyso-some	NULL
»	NULL
macrophage	NULL
«	NULL
differentiation	NULL
«	NULL
LAL-promoter	NULL
«	NULL
transcription	NULL
factors	NULL
»	NULL
gene	NULL
regulation	NULL
«	NULL
Wolman	NULL
disease	NULL
»	NULL
cholesteryl	NULL
ester	NULL
storage	NULL
disease	NULL
Human	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
(	NULL
LAL	NULL
;	NULL
E.C	NULL
.	NULL

3.1.1.13	NULL
)	NULL
catalyzes	NULL
the	NULL
hydrolysis	NULL
of	NULL
both	NULL
cholesteryl	NULL
esters	NULL
and	NULL
triglycerides	NULL
that	NULL
are	NULL
delivered	NULL
to	NULL
lysosomes	NULL
by	NULL
low	NULL
density	NULL
lipoprotein	NULL
(	NULL
LDL	NULL
)	NULL
receptormediated	NULL
endocytosis	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Free	NULL
cholesterol	NULL
is	NULL
released	NULL
from	NULL
lysosomes	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
acyl-CoA	NULL
:	NULL
cholesterol	NULL
acyltransferase	NULL
(	NULL
ACAT	NULL
)	NULL
and	NULL
to	NULL
down-regulation	NULL
of	NULL
LDL	NULL
receptor	NULL
gene	NULL
expression	NULL
and	NULL
HMG-CoA	NULL
reductase	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
LAL	NULL
contributes	NULL
to	NULL
the	NULL
homeostatic	NULL
control	NULL
of	NULL
plasma	NULL
lipoprotein	NULL
levels	NULL
and	NULL
to	NULL
the	NULL
prevention	NULL
of	NULL
cellular	NULL
lipid	NULL
overload	NULL
in	NULL
liver	NULL
,	NULL
spleen	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
of	NULL
the	NULL
arterial	NULL
wall	NULL
(	NULL
2	NULL
)	NULL
.	NULL

LAL	NULL
activity	NULL
is	NULL
significantly	NULL
reduced	NULL
in	NULL
mononuclear	NULL
cells	NULL
from	NULL
patients	NULL
suffering	NULL
from	NULL
premature	NULL
coronary	NULL
heart	NULL
disease	NULL
and	NULL
familial	NULL
hypercholesterolemia	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
LAL	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
atherosclerosis	NULL
is	NULL
also	NULL
emphasized	NULL
by	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
autosomal	NULL
recessive	NULL
disease	NULL
,	NULL
namely	NULL
cholesteryl	NULL
ester	NULL
storage	NULL
disease	NULL
(	NULL
CESD	NULL
)	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
disorder	NULL
LAL	NULL
activity	NULL
is	NULL
reduced	NULL
due	NULL
to	NULL
mutations	NULL
within	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
patients	NULL
with	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
LAL	NULL
activity	NULL
{	NULL
(	NULL
Wolman	NULL
disease	NULL
)	NULL
die	NULL
within	NULL
the	NULL
first	NULL
year	NULL
of	NULL
life	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

The	NULL
LAL	NULL
gene	NULL
is	NULL
approximately	NULL
36	NULL
kb	NULL
long	NULL
,	NULL
consists	NULL
of	NULL
10	NULL
exons	NULL
,	NULL
and	NULL
is	NULL
transcribed	NULL
as	NULL
a	NULL
2.4	NULL
kb	NULL
long	NULL
mRNA	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Mature	NULL
macrophages	NULL
extend	NULL
their	NULL
lysosomal	NULL
compartment	NULL
required	NULL
for	NULL
intracellular	NULL
degradation	NULL
processes	NULL
,	NULL
and	NULL
therefore	NULL
enhanced	NULL
expression	NULL
of	NULL
lysosomal	NULL
enzymes	NULL
is	NULL
expected	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
LAL	NULL
expression	NULL
in	NULL
differentiating	NULL
monocytes/	NULL
macrophages	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
both	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
the	NULL
human	NULL
promono-cytic	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
may	NULL
be	NULL
induced	NULL
toward	NULL
a	NULL
macrophage	NULL
like	NULL
state	NULL
by	NULL
culture	NULL
with	NULL
phorbol	NULL
esters	NULL
;	NULL
this	NULL
is	NULL
characterized	NULL
by	NULL
adherence	NULL
,	NULL
increased	NULL
phagocytic	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
lysozyme	NULL
and	NULL
non-specific	NULL
esterase	NULL
activities	NULL
(	NULL
14	NULL
)	NULL
.	NULL

THP-1	NULL
cells	NULL
thus	NULL
provide	NULL
a	NULL
useful	NULL
in	NULL
vitro	NULL
model	NULL
to	NULL
investigate	NULL
biological	NULL
properties	NULL
of	NULL
macrophages	NULL
.	NULL

Recently	NULL
,	NULL
many	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
alteration	NULL
of	NULL
gene	NULL
expression	NULL
Abbreviations	NULL
:	NULL
LAL	NULL
,	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
;	NULL
M-CSF	NULL
,	NULL
macrophage-colony	NULL
stimulating	NULL
factor	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate-l3-acetate	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
SR-A	NULL
,	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
;	NULL
EGR	NULL
,	NULL
early	NULL
growth	NULL
response	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
TSS	NULL
,	NULL
transcriptional	NULL
start	NULL
site	NULL
;	NULL
TBP	NULL
,	NULL
TATA-box	NULL
binding	NULL
protein	NULL
.	NULL

'To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
2125	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
that	NULL
occurs	NULL
along	NULL
with	NULL
the	NULL
maturation	NULL
of	NULL
macrophages	NULL
.	NULL

For	NULL
example	NULL
,	NULL
expression	NULL
of	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
,	NULL
vacuolar	NULL
H*+-AT	NULL
Pase	NULL
,	NULL
and	NULL
several	NULL
lysosomal	NULL
enzymes	NULL
like	NULL
cathepsin	NULL
L	NULL
are	NULL
induced	NULL
during	NULL
differentiation	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
LAL	NULL
expression	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
and	NULL
provide	NULL
evidence	NULL
for	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
.	NULL

As	NULL
the	NULL
putative	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
has	NULL
been	NULL
cloned	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
and	NULL
promoter	NULL
elements	NULL
responsible	NULL
for	NULL
transcriptional	NULL
control	NULL
were	NULL
characterized	NULL
.	NULL

A	NULL
genomic	NULL
fragment	NULL
182	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
possesses	NULL
full	NULL
promoter	NULL
activity	NULL
,	NULL
that	NULL
is	NULL
inducible	NULL
up	NULL
to	NULL
3.5-fold	NULL
in	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

Binding	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
specific	NULL
promoter	NULL
elements	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Our	NULL
data	NULL
clearly	NULL
indicate	NULL
that	NULL
transcriptional	NULL
induction	NULL
of	NULL
LAL	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
concerted	NULL
action	NULL
of	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP2	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
Phorbol	NULL
12-myristate-l3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitors	NULL
,	NULL
staurosporine	NULL
and	NULL
H7	NULL
(	NULL
1-	NULL
[	NULL
5isoquinolonesulfonyl	NULL
]	NULL
2-methylpiperazine	NULL
dihydrochloride	NULL
)	NULL
,	NULL
actinomycin	NULL
D	NULL
,	NULL
chloroquine	NULL
,	NULL
DEAE-dextran	NULL
,	NULL
and	NULL
cycloheximide	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Human	NULL
recombinant	NULL
M-CSF	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
THP-1	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Eggenstein	NULL
)	NULL
,	NULL
100	NULL
U	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
pug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
in	NULL
10	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
37°C	NULL
.	NULL

To	NULL
induce	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
normolipidemic	NULL
volunteers	NULL
by	NULL
leukapheresis	NULL
and	NULL
subsequent	NULL
counterflow	NULL
centrifugation	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Fractions	NULL
containing	NULL
>	NULL
90	NULL
%	NULL
CD14	NULL
positive	NULL
cells	NULL
were	NULL
pooled	NULL
and	NULL
cultured	NULL
for	NULL
7	NULL
days	NULL
on	NULL
plastic	NULL
petri	NULL
dishes	NULL
in	NULL
macrophage	NULL
SFM	NULL
medium	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Eggenstein	NULL
)	NULL
supplemented	NULL
with	NULL
50	NULL
ng/	NULL
ml	NULL
human	NULL
recombinant	NULL
M-CSF	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analyses	NULL
Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Eggenstein	NULL
)	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
isothiocyanate/	NULL
cesium	NULL
chloride	NULL
ultracentrifugation	NULL
method	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Ten	NULL
pug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
1.2	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
6	NULL
%	NULL
formaldehyde	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
GeneScreen	NULL
Plus	NULL
,	NULL
DuPont	NULL
,	NULL
Bad	NULL
Homburg	NULL
)	NULL
,	NULL
and	NULL
UV	NULL
crosslinked	NULL
.	NULL

LAL	NULL
specific	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
hybridization	NULL
using	NULL
a	NULL
1.2	NULL
kb	NULL
cDNA	NULL
fragment	NULL
generated	NULL
by	NULL
PCR	NULL
with	NULL
LAC1/	NULL
LAC2	NULL
primers	NULL
radiolabeled	NULL
using	NULL
the	NULL
Oligolabeling	NULL
kit	NULL
(	NULL
Pharmacia	NULL
,	NULL
Freiburg	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
membranes	NULL
.	NULL

The	NULL
primer	NULL
sequences	NULL
for	NULL
LAC1	NULL
and	NULL
LACZ2	NULL
were	NULL
5-CCCGGCAGGA	NULL
CAGCTCCAGA-3	NULL
'	NULL
and	NULL
5'-GTGTGACACAGCTCAAGTCCAGC	NULL
TT-3	NULL
'	NULL
,	NULL
respectively	NULL
.	NULL

Hybridization	NULL
and	NULL
wash	NULL
conditions	NULL
were	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
DuPont	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Sub-sequently	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
AR	NULL
X-Omat	NULL
films	NULL
at	NULL
-70°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

2126	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
Ribonuclease	NULL
protection	NULL
assay	NULL
An	NULL
LAL	NULL
specific	NULL
cDNA	NULL
probe	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
primers	NULL
LACup	NULL
5'-CAAGGATCCACGATTACCAGATCATCTCA	NULL
TTAAG3	NULL
'	NULL
and	NULL
LACdown	NULL
5'-TAGAATTCTGGCTCCAGTGTAA	NULL
CATGTTTTGC-3	NULL
'	NULL
and	NULL
cloned	NULL
into	NULL
a	NULL
pGEM4Z	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
radiolabeled	NULL
cRNA	NULL
probes	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
linearized	NULL
and	NULL
transcribed	NULL
in	NULL
vitro	NULL
using	NULL
e	NULL
[	NULL
°2P	NULL
]	NULL
CTP	NULL
and	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
.	NULL

The	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
RNase	NULL
protection	NULL
kit	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
number	NULL
of	NULL
transcriptional	NULL
start	NULL
sites	NULL
,	NULL
two	NULL
overlapping	NULL
genomic	NULL
fragments	NULL
PAl	NULL
and	NULL
PAZ	NULL
,	NULL
spanning	NULL
from	NULL
-219	NULL
to	NULL
+59	NULL
and	NULL
-109	NULL
to	NULL
+59	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
were	NULL
PCR	NULL
amplified	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
plasmid	NULL
vector	NULL
pGEMA4Z	NULL
.	NULL

The	NULL
P1	NULL
fragment	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
primers	NULL
SR1-up	NULL
5-CCGGGATCCAGCCTGCGAGGCGGAGGACG-3	NULL
'	NULL
and	NULL
SR-down	NULL
-	NULL
The	NULL
probe	NULL
PAZ	NULL
was	NULL
generated	NULL
using	NULL
SR2up	NULL
S'CCTGGATCCGAG	NULL
GCACTTCCCGGTGGCTG-3	NULL
'	NULL
in	NULL
combination	NULL
with	NULL
SR-down	NULL
.	NULL

Nuclear	NULL
run-on	NULL
analyses	NULL
Nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
nuclei	NULL
from	NULL
resting	NULL
THP-1	NULL
cells	NULL
and	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

For	NULL
each	NULL
nuclear	NULL
run-on	NULL
experiment	NULL
,	NULL
2	NULL
X	NULL
10	NULL
``	NULL
nuclei	NULL
were	NULL
used	NULL
.	NULL

The	NULL
LAC1/	NULL
LAC2-amplified	NULL
1.2	NULL
kb	NULL
LAL	NULL
cDNA	NULL
fragment	NULL
and	NULL
cDNA	NULL
fragments	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
and	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
(	NULL
SR-A	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pUC18	NULL
plasmid	NULL
vector	NULL
(	NULL
Pharmacia	NULL
,	NULL
Freiburg	NULL
)	NULL
.	NULL

Five	NULL
pg	NULL
of	NULL
these	NULL
plasmids	NULL
was	NULL
linearized	NULL
,	NULL
alkaline	NULL
denatured	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schiill	NULL
,	NULL
Dassel	NULL
)	NULL
,	NULL
using	NULL
the	NULL
pUC18	NULL
vector	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
of	NULL
the	NULL
membranes	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Srivastava	NULL
,	NULL
Cable	NULL
,	NULL
and	NULL
Bonkovsky	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Immunoblotting	NULL
Cells	NULL
were	NULL
first	NULL
homogenized	NULL
by	NULL
sonication	NULL
and	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
in	NULL
a	NULL
Mini	NULL
Protean	NULL
II	NULL
electrophoresis	NULL
chamber	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
transferred	NULL
onto	NULL
the	NULL
PVDF	NULL
FluoroTrans	NULL
``	NULL
*	NULL
``	NULL
membrane	NULL
(	NULL
Pall	NULL
,	NULL
Dreieich	NULL
)	NULL
using	NULL
the	NULL
Trans-Blot®	NULL
semi-dry	NULL
transfer	NULL
cell	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Blocking	NULL
was	NULL
done	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
5	NULL
%	NULL
non	NULL
-fatty	NULL
dried	NULL
milk	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
1h	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
polyclonal	NULL
rabbit	NULL
anti-serum	NULL
against	NULL
recombinant	NULL
LAL	NULL
from	NULL
£	NULL
.	NULL

coli	NULL
(	NULL
dilution	NULL
1:1000	NULL
in	NULL
blocking	NULL
buffer	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
anti-LAL	NULL
antibodies	NULL
was	NULL
performed	NULL
by	NULL
a	NULL
14	NULL
incubation	NULL
with	NULL
a	NULL
1:5000	NULL
dilution	NULL
of	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
antitabbit	NULL
immunoglobulin	NULL
(	NULL
Dianova	NULL
,	NULL
Hamburg	NULL
)	NULL
.	NULL

Unbound	NULL
antibody	NULL
was	NULL
removed	NULL
by	NULL
extensive	NULL
washing	NULL
after	NULL
each	NULL
incubation	NULL
step	NULL
.	NULL

The	NULL
bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
with	NULL
the	NULL
ECL	NULL
**	NULL
Western	NULL
blotting	NULL
detection	NULL
reagent	NULL
(	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
Nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
and	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

THP-1	NULL
cells	NULL
(	NULL
5	NULL
%	NULL
10	NULL
``	NULL
)	NULL
were	NULL
used	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
ali-quoted	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
each	NULL
nuclear	NULL
extract	NULL
has	NULL
been	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
LAL	NULL
gene	NULL
promoter/	NULL
luciferase	NULL
chimeras	NULL
The	NULL
various	NULL
5	NULL
'	NULL
regions	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
were	NULL
generated	NULL
by	NULL
means	NULL
of	NULL
PCR	NULL
using	NULL
specific	NULL
primers	NULL
for	NULL
each	NULL
construct	NULL
and	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
promoterless	NULL
pGL3-basic	NULL
luciferase	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Primers	NULL
for	NULL
pLAL1	NULL
were	NULL
Pro	NULL
2586	NULL
5-TTTGGTACCCCC	NULL
ACATGCTCTCTGTCAGGCGCAGAAG3	NULL
'	NULL
and	NULL
Pro3005i	NULL
5'-ACA	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
GATCTCTGGAGCTGTCCTGCCGGGCCGCT	NULL
G-3	NULL
'	NULL
;	NULL
for	NULL
pLAL2	NULL
,	NULL
Pro2730	NULL
_	NULL
5'-GCCGGTACCGCGGAGGACGGGCTCCATCTCTITT	NULL
AG3	NULL
'	NULL
and	NULL
Pro3005i	NULL
;	NULL
for	NULL
pLAL3	NULL
,	NULL
Pro2740	NULL
5'-GGGCTAGCGAA	NULL
ACGCCTACGGCGCATGCTCTAT-3	NULL
'	NULL
and	NULL
Pro3005i	NULL
;	NULL
for	NULL
pLAL4	NULL
,	NULL
Pro2750	NULL
5-GGGCTAGCGGGGTCAACTGGGGGGCTG	NULL
GCAAGC-3	NULL
'	NULL
and	NULL
Pro3005i	NULL
;	NULL
for	NULL
pLALS5	NULL
,	NULL
Pro2780	NULL
5-GGGCTAGCGGCAG	NULL
CGCTGGTCTGGGGCGGAGTCT3	NULL
'	NULL
and	NULL
Pro3005i	NULL
;	NULL
for	NULL
pLAL6	NULL
,	NULL
Pro2830	NULL
5-CGGGTACCCCGAGGCACTTCCCGGTGG	NULL
CTGGC-3	NULL
'	NULL
and	NULL
Pro3005i	NULL
;	NULL
for	NULL
pLAL7	NULL
,	NULL
Pro2805	NULL
5-GGGCTAGCTGCTCT	NULL
GATTGGCTGAACAAATAGTC-3	NULL
'	NULL
and	NULL
Pro30051	NULL
.	NULL

The	NULL
PCR	NULL
conditions	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
purified	NULL
by	NULL
Qiaex	NULL
(	NULL
Qiagen	NULL
,	NULL
Hilden	NULL
)	NULL
,	NULL
digested	NULL
with	NULL
Bgill	NULL
and	NULL
KpnI	NULL
(	NULL
pLAL1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
BgilI	NULL
and	NULL
Nhe	NULL
(	NULL
pLAL3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pGL3-basic	NULL
luciferase	NULL
vector	NULL
All	NULL
LAL/	NULL
luciferase	NULL
fusion	NULL
constructs	NULL
had	NULL
a	NULL
common	NULL
3	NULL
'	NULL
terminus	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
located	NULL
at	NULL
nucleotide	NULL
+67	NULL
,	NULL
with	NULL
the	NULL
fused	NULL
promoter	NULL
fragment	NULL
varying	NULL
in	NULL
length	NULL
from	NULL
149	NULL
bp	NULL
to	NULL
419	NULL
bp	NULL
.	NULL

The	NULL
LAL	NULL
gene	NULL
promoter/	NULL
luciferase	NULL
constructs	NULL
were	NULL
sequenced	NULL
prior	NULL
to	NULL
use	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
THP-1	NULL
cells	NULL
and	NULL
luciferase	NULL
assays	NULL
For	NULL
each	NULL
experiment	NULL
5	NULL
X	NULL
10	NULL
``	NULL
THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pug	NULL
reporter	NULL
plasmid	NULL
DNA	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Two	NULL
jug	NULL
of	NULL
pSVB-galactosidase	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
included	NULL
in	NULL
all	NULL
assays	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
to	NULL
-galactosidase	NULL
activities	NULL
.	NULL

In	NULL
co-transfection	NULL
experiments	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
expression	NULL
vector	NULL
or	NULL
pUC18	NULL
plasmid	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
was	NULL
added	NULL
.	NULL

To	NULL
increase	NULL
transfection	NULL
efficiency	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
wm	NULL
chloroquine	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
chloroquine	NULL
,	NULL
cells	NULL
were	NULL
resus-pended	NULL
in	NULL
30	NULL
ml	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
,	NULL
divided	NULL
into	NULL
two	NULL
75-cm	NULL
>	NULL
culture	NULL
flasks	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
24	NULL
h.	NULL
PMA	NULL
(	NULL
160	NULL
nm	NULL
)	NULL
was	NULL
added	NULL
to	NULL
one	NULL
flask	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Forty-eight	NULL
h	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
Lumat	NULL
LB9501	NULL
(	NULL
Berthold	NULL
,	NULL
Munich	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

B-Gal	NULL
activity	NULL
was	NULL
evaluated	NULL
in	NULL
a	NULL
standard	NULL
color	NULL
reaction	NULL
to	NULL
detect	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
An	NULL
equivalent	NULL
of	NULL
30,000	NULL
cpm	NULL
of	NULL
labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
desired	NULL
promoter	NULL
sequence	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
HEPES/	NULL
HCJ	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
di	NULL
A	NULL
monocytes	NULL
-	NULL
B	NULL
THP-1+	NULL
PMA	NULL
@	NULL
»	NULL
*	NULL
0	NULL
3	NULL
6	NULL
9	NULL
12	NULL
24	NULL
48	NULL
hours	NULL
thiothreitol	NULL
,	NULL
100	NULL
ug/	NULL
ml	NULL
BSA	NULL
,	NULL
0.01	NULL
%	NULL
NP4O0	NULL
,	NULL
and	NULL
2	NULL
jg	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
,	NULL
Freiburg	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Supershift	NULL
analyses	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
antibodies	NULL
against	NULL
Spl	NULL
and	NULL
AP-2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
Spl	NULL
,	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
against	NULL
residues	NULL
436-454	NULL
was	NULL
used	NULL
(	NULL
catalog	NULL
number	NULL
sc-59x	NULL
)	NULL
and	NULL
AP-2	NULL
binding	NULL
was	NULL
examined	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
against	NULL
residues	NULL
420-437	NULL
(	NULL
catalog	NULL
number	NULL
sc-184x	NULL
)	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
through	NULL
8	NULL
%	NULL
poly-acrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
RESULTS	NULL
Characterization	NULL
of	NULL
LAL	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
To	NULL
study	NULL
the	NULL
mechanisms	NULL
regulating	NULL
differentiation	NULL
dependent	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
(	NULL
LAL	NULL
)	NULL
expression	NULL
in	NULL
mono-cytes	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analyses	NULL
on	NULL
total	NULL
cellular	NULL
RNA	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

Figure	NULL
1	NULL
A	NULL
shows	NULL
a	NULL
Northern	NULL
blot	NULL
hybridized	NULL
with	NULL
a	NULL
1.2	NULL
kb	NULL
long	NULL
cDNA	NULL
fragment	NULL
generated	NULL
with	NULL
the	NULL
LAL	NULL
primers	NULL
LAC1	NULL
and	NULL
LAC2	NULL
.	NULL

Steady	NULL
state	NULL
levels	NULL
of	NULL
LAL	NULL
mRNA	NULL
increase	NULL
during	NULL
differentiation	NULL
.	NULL

Quantification	NULL
of	NULL
LAL	NULL
mRNA	NULL
was	NULL
achieved	NULL
with	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
using	NULL
an	NULL
RNA	NULL
probe	NULL
containing	NULL
an	NULL
LAL-specific	NULL
sequence	NULL
located	NULL
+720	NULL
to	NULL
+963	NULL
downstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

We	NULL
allowed	NULL
the	NULL
probe	NULL
to	NULL
hybridize	NULL
to	NULL
10	NULL
pug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
monocytes	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
cultivated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng/	NULL
ml	NULL
human	NULL
recombinant	NULL
M-CSF	NULL
for	NULL
7	NULL
days	NULL
,	NULL
or	NULL
to	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
yeast	NULL
t-RNA	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
measurement	NULL
of	NULL
the	NULL
protected	NULL
RNA	NULL
fragments	NULL
after	NULL
gel	NULL
electrophoresis	NULL
revealed	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
LAL	NULL
mRNA	NULL
induction	NULL
up	NULL
to	NULL
12.4-fold	NULL
after	NULL
7	NULL
days	NULL
cultivation	NULL
{	NULL
numbers	NULL
in	NULL
boxes	NULL
below	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
regulation	NULL
also	NULL
occurs	NULL
in	NULL
the	NULL
leukemia	NULL
cell	NULL
line	NULL
THP	NULL
we	NULL
analyzed	NULL
the	NULL
LAL	NULL
mRNA	NULL
expression	NULL
pattern	NULL
in	NULL
THP-1	NULL
cells	NULL
differentiated	NULL
with	NULL
PMA	NULL
by	NULL
Northern	NULL
blots	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
LAL	NULL
mRNA	NULL
increased	NULL
after	NULL
PMA	NULL
treatment	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
LAL	NULL
mRNA	NULL
dur-	NULL
LAL	NULL
ing	NULL
differentiation	NULL
of	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

mRNA	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
(	NULL
A	NULL
)	NULL
human	NULL
blood	NULL
monocytes	NULL
(	NULL
day	NULL
0	NULL
)	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
day	NULL
7	NULL
)	NULL
,	NULL
or	NULL
(	NULL
B	NULL
)	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Each	NULL
lane	NULL
was	NULL
loaded	NULL
with	NULL
10	NULL
g	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
.	NULL

Northern	NULL
hybridization	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
[	NULL
*P	NULL
]	NULL
labeled	NULL
1.2	NULL
kb	NULL
LAL	NULL
cDNA	NULL
fragment	NULL
generated	NULL
with	NULL
LAC1	NULL
and	NULL
LACZ	NULL
.	NULL

The	NULL
induction	NULL
factor	NULL
of	NULL
LAL	NULL
mRNA	NULL
levels	NULL
is	NULL
depicted	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

The	NULL
ethidium	NULL
bromide	NULL
stained	NULL
agarose	NULL
gel	NULL
showing	NULL
the	NULL
288	NULL
rRNA	NULL
confirms	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

1	NULL
[	NULL
12.4	NULL
1	NULL
|	NULL
1.9	NULL
|	NULL
1.9	NULL
|	NULL
3.2	NULL
|	NULL
8.5	NULL
|	NULL
11.1	NULL
}	NULL
16.2	NULL
|	NULL
-fold	NULL
induction	NULL
Ries	NULL
e	NULL
al	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
by	NULL
Spl	NULL
and	NULL
Ap-2	NULL
2127	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
A	NULL
PMA	NULL
Treatment	NULL
(	NULL
160	NULL
nM	NULL
)	NULL
B	NULL
Oh	NULL
24h	NULL
pUC18	NULL
THP-1	NULL
-PMA	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Comparison	NULL
of	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
LAL	NULL
mRNA	NULL
induction	NULL
.	NULL

A	NULL
:	NULL
Nuclear	NULL
run-on	NULL
analysis	NULL
of	NULL
LAL	NULL
mRNA	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
resting	NULL
THP-1	NULL
cells	NULL
(	NULL
0	NULL
h	NULL
)	NULL
and	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
24	NULL
h	NULL
)	NULL
.	NULL

Nascent	NULL
transcripts	NULL
were	NULL
labeled	NULL
with	NULL
«	NULL
[	NULL
°*P	NULL
]	NULL
UTP	NULL
and	NULL
hybridized	NULL
to	NULL
cDNA	NULL
fragments	NULL
for	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
,	NULL
glyc-	NULL
SRA	NULL
~	NULL
eraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
pUC18	NULL
,	NULL
and	NULL
the	NULL
LAL	NULL
1.2	NULL
kb	NULL
cDNA	NULL
probe	NULL
generated	NULL
Oh	NULL
0.5h	NULL
1th	NULL
2h	NULL
4h	NULL
8h	NULL
THP-1	NULL
+PMA	NULL
with	NULL
primers	NULL
LAC1	NULL
and	NULL
LAC2	NULL
,	NULL
immobilized	NULL
on	NULL
nylon	NULL
membranes	NULL
.	NULL

B	NULL
:	NULL
Analysis	NULL
of	NULL
LAL	NULL
mRNA	NULL
stability	NULL
in	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

LAL	NULL
Cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
for	NULL
24	NULL
h.	NULL
After	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
8	NULL
ug/	NULL
5	NULL
I	NULL
1	NULL
I	NULL
1	NULL
GAPDH	NULL
Oh	NULL
0.Sh	NULL
1th	NULL
2h	NULL
C	NULL
Monocytes	NULL
+	NULL
M-CSF	NULL
4h	NULL
Bh	NULL
THP-1	NULL
+	NULL
PMA	NULL
ml	NULL
)	NULL
to	NULL
either	NULL
differentiated	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
or	NULL
undifferentiated	NULL
cells	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

RNA	NULL
samples	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

C	NULL
:	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cellular	NULL
LAL	NULL
protein	NULL
in	NULL
differentiating	NULL
monocytes	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
--	NULL
--	NULL
**	NULL
|	NULL
+	NULL
LAL	NULL
-+-	NULL
(	NULL
41kDa	NULL
)	NULL
from	NULL
freshly	NULL
isolated	NULL
blood	NULL
monocytes	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
that	NULL
were	NULL
cultured	NULL
on	NULL
0	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
days	NULL
0	NULL
-	NULL
1	NULL
2	NULL
3	NULL
Lysosomal	NULL
acid	NULL
lipase	NULL
is	NULL
regulated	NULL
both	NULL
at	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
levels	NULL
To	NULL
examine	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
processes	NULL
responsible	NULL
for	NULL
the	NULL
higher	NULL
LAL	NULL
mRNA	NULL
levels	NULL
,	NULL
rates	NULL
of	NULL
synthesis	NULL
and	NULL
degradation	NULL
of	NULL
LAL	NULL
mRNA	NULL
were	NULL
determined	NULL
in	NULL
nuclear	NULL
run-on	NULL
and	NULL
actinomycin	NULL
D	NULL
experiments	NULL
.	NULL

Nascent	NULL
transcripts	NULL
from	NULL
untreated	NULL
and	NULL
PMA-treated	NULL
(	NULL
24	NULL
h	NULL
)	NULL
THP-1	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
«	NULL
[	NULL
*P	NULL
]	NULL
UTP	NULL
and	NULL
hybridized	NULL
to	NULL
an	NULL
LAL-specific	NULL
plastic	NULL
petri	NULL
dishes	NULL
for	NULL
various	NULL
times	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng/	NULL
ml	NULL
M-CSF	NULL
and	NULL
from	NULL
THP-1	NULL
cells	NULL
incubated	NULL
with	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

Proteins	NULL
(	NULL
10	NULL
ug/	NULL
lane	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
against	NULL
a	NULL
polyclonal	NULL
LAL	NULL
antiserum	NULL
.	NULL

cDNA	NULL
fragment	NULL
,	NULL
a	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
cDNA	NULL
plasmid	NULL
,	NULL
a	NULL
GAPDH	NULL
cDNA	NULL
plasmid	NULL
,	NULL
and	NULL
a	NULL
pUC	NULL
18	NULL
vector	NULL
.	NULL

Scavenger	NULL
receptor	NULL
type	NULL
A	NULL
is	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
transcrip-tionally	NULL
in	NULL
THP-1	NULL
cells	NULL
immediately	NULL
upon	NULL
monocytic	NULL
differentiation	NULL
,	NULL
which	NULL
is	NULL
induced	NULL
by	NULL
PMA	NULL
,	NULL
and	NULL
was	NULL
thus	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
LAL	NULL
transcript	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
resting	NULL
THP-1	NULL
cells	NULL
and	NULL
increased	NULL
substantially	NULL
24	NULL
h	NULL
after	NULL
PMA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Densitomet-ric	NULL
scanning	NULL
of	NULL
autoradiograms	NULL
indicated	NULL
that	NULL
transcrip-	NULL
A	NULL
THP	NULL
B	NULL
THP	NULL
#	NULL
#	NULL
``	NULL
|	NULL
*	NULL
mRNA	NULL
«	NULL
»	NULL
_	NULL
am	NULL
-'-	NULL
4_rfI-SPITNA	NULL
L	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
10	NULL
2	NULL
3	NULL
4	NULL
§	NULL
PMA	NULL
+	NULL
|	NULL
-	NULL
|	NULL
+	NULL
[	NULL
+	NULL
|	NULL
+	NULL
PMA	NULL
-	NULL
[	NULL
+	NULL
]	NULL
-	NULL
[	NULL
+	NULL
|	NULL
actD	NULL
=	NULL
[	NULL
=	NULL
|	NULL
#	NULL
|	NULL
=	NULL
|	NULL
=	NULL
CHX	NULL
-	NULL
|	NULL
+	NULL
]	NULL
+	NULL
]	NULL
-	NULL
|	NULL
~	NULL
stauro	NULL
-	NULL
|	NULL
-	NULL
|J	NULL
-	NULL
|	NULL
+	NULL
]	NULL
-	NULL
DMSO	NULL
-	NULL
|	NULL
+	NULL
[	NULL
+	NULL
}	NULL
-	NULL
|	NULL
+	NULL
H7	NULL
-	NULL
|	NULL
-	NULL
[	NULL
-|	NULL
-	NULL
[	NULL
+	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
LAL	NULL
mRNA	NULL
depends	NULL
on	NULL
PKC	NULL
activity	NULL
and	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

A	NULL
:	NULL
Northern	NULL
analysis	NULL
demonstrating	NULL
the	NULL
effect	NULL
of	NULL
PKC	NULL
inhibitors	NULL
on	NULL
PMA-induced	NULL
LAL	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
8	NULL
g/	NULL
m1	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
nw	NULL
staurosporine	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
um	NULL
H7	NULL
.	NULL

B	NULL
:	NULL
Ribonuclease	NULL
protection	NULL
assay	NULL
demon	NULL
strating	NULL
the	NULL
effect	NULL
of	NULL
cycloheximide	NULL
on	NULL
PMA	NULL
induced	NULL
LAL	NULL
expression	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
RNA	NULL
from	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
THP-1	NULL
cells	NULL
preincubated	NULL
with	NULL
10	NULL
jwg/	NULL
ml	NULL
cycloheximide	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
160	NULL
nm	NULL
PMA	NULL
for	NULL
14	NULL
h	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
THP-1	NULL
cells	NULL
cultured	NULL
with	NULL
10	NULL
g/	NULL
ml	NULL
cycloheximide	NULL
for	NULL
14	NULL
h	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
for	NULL
14	NULL
h	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
THP-1	NULL
cells	NULL
incubated	NULL
with	NULL
DMSO	NULL
(	NULL
solvent	NULL
)	NULL
.	NULL

2128	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
tion	NULL
was	NULL
induced	NULL
approximately	NULL
4.9-fold	NULL
in	NULL
THP-l	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h.	NULL
In	NULL
comparison	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
GAPDH	NULL
gene	NULL
remained	NULL
relatively	NULL
constant	NULL
after	NULL
PMA	NULL
incubation	NULL
.	NULL

Because	NULL
a	NULL
basal	NULL
LAL	NULL
mRNA	NULL
expression	NULL
is	NULL
detectable	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
observed	NULL
4.9-fold	NULL
increase	NULL
after	NULL
PMA	NULL
stimulation	NULL
might	NULL
also	NULL
be	NULL
due	NULL
to	NULL
altered	NULL
mRNA	NULL
stability	NULL
.	NULL

For	NULL
a	NULL
number	NULL
of	NULL
other	NULL
genes	NULL
,	NULL
PMA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
gene	NULL
expression	NULL
by	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
enhancement	NULL
of	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
corresponding	NULL
mature	NULL
mRNA	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
potential	NULL
posttranscriptional	NULL
control	NULL
of	NULL
LAL	NULL
mRNA	NULL
expression	NULL
,	NULL
actinomycin	NULL
D	NULL
(	NULL
8	NULL
mg/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
undifferentiated	NULL
or	NULL
PMA-exposed	NULL
THP-1	NULL
cells	NULL
.	NULL

RNA	NULL
extracted	NULL
at	NULL
different	NULL
times	NULL
from	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
after	NULL
actinomycin	NULL
D	NULL
treatment	NULL
were	NULL
subjected	NULL
to	NULL
RNase	NULL
protection	NULL
analysis	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
LAL	NULL
mRNA	NULL
from	NULL
undifferentiated	NULL
THP-1	NULL
cells	NULL
was	NULL
eliminated	NULL
more	NULL
rapidly	NULL
when	NULL
transcription	NULL
was	NULL
inhibited	NULL
by	NULL
actinomycin	NULL
D	NULL
(	NULL
40	NULL
%	NULL
of	NULL
control	NULL
after	NULL
4	NULL
h	NULL
)	NULL
.	NULL

In	NULL
PMA-differentiated	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
LAL	NULL
mRNA	NULL
was	NULL
unaffected	NULL
up	NULL
to	NULL
8	NULL
h.	NULL
These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
LAL	NULL
mRNA	NULL
is	NULL
degraded	NULL
faster	NULL
in	NULL
resting	NULL
THP-1	NULL
cells	NULL
than	NULL
in	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

Immunoblots	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
THP	NULL
-1	NULL
cells	NULL
clearly	NULL
demonstrate	NULL
that	NULL
more	NULL
LAL	NULL
protein	NULL
is	NULL
synthesized	NULL
as	NULL
a	NULL
result	NULL
of	NULL
higher	NULL
LAL	NULL
mRNA	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
PMAenhanced	NULL
LAL	NULL
expression	NULL
occurs	NULL
both	NULL
on	NULL
transcriptional	NULL
and	NULL
post-tran	NULL
scriptional	NULL
levels	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

PMA-induced	NULL
LAL	NULL
mRNA	NULL
up-regulation	NULL
depends	NULL
on	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
and	NULL
new	NULL
protein	NULL
synthesis	NULL
Inhibitors	NULL
of	NULL
the	NULL
PKC	NULL
path	NULL
way	NULL
were	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
PMA	NULL
to	NULL
characterize	NULL
the	NULL
signal	NULL
transduction	NULL
path	NULL
ways	NULL
in	NULL
volved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
LAL	NULL
gene	NULL
expression	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
the	NULL
PKC	NULL
inhibitors	NULL
,	NULL
staurosporine	NULL
and	NULL
H7	NULL
,	NULL
caused	NULL
a	NULL
remarkable	NULL
decrease	NULL
of	NULL
LAL	NULL
mRNA	NULL
in	NULL
PMA-stimulated	NULL
THP	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
not	NULL
affected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
PMA	NULL
and	NULL
cycloheximide	NULL
completely	NULL
abolished	NULL
up-regulation	NULL
of	NULL
LAL	NULL
mRNA	NULL
,	NULL
while	NULL
cycloheximide	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
LAL	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
during	NULL
PMA-induced	NULL
monocytic	NULL
differentiation	NULL
is	NULL
dependent	NULL
upon	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
requires	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

Mapping	NULL
of	NULL
LAL	NULL
transcriptional	NULL
start	NULL
sites	NULL
5	NULL
'	NULL
RACE-PCR	NULL
analysis	NULL
indicated	NULL
two	NULL
different	NULL
transcription	NULL
start	NULL
points	NULL
for	NULL
the	NULL
LAL	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
putative	NULL
promoter	NULL
region	NULL
is	NULL
(	NULL
G	NULL
+	NULL
C	NULL
)	NULL
-rich	NULL
and	NULL
is	NULL
deficient	NULL
of	NULL
a	NULL
TATA-box	NULL
.	NULL

The	NULL
exact	NULL
position	NULL
of	NULL
the	NULL
multiple	NULL
LAL	NULL
mRNA	NULL
start	NULL
sites	NULL
was	NULL
determined	NULL
using	NULL
two	NULL
antisense	NULL
RNA	NULL
probes	NULL
(	NULL
PA1l	NULL
,	NULL
PAZ	NULL
)	NULL
derived	NULL
from	NULL
a	NULL
genomic	NULL
clone	NULL
.	NULL

These	NULL
probes	NULL
were	NULL
hybridized	NULL
to	NULL
different	NULL
amounts	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
rest	NULL
+	NULL
PA1	NULL
+	NULL
#	NULL
|	NULL
PA2_	NULL
+	NULL
PMA	NULL
tRNA	NULL
RNase	NULL
+/+	NULL
+	NULL
]	NULL
+	NULL
]	NULL
|+	NULL
oa	NULL
|+	NULL
o	NULL
sio	NULL
[	NULL
4+	NULL
]	NULL
+	NULL
]	NULL
a	NULL
®	NULL
[	NULL
+/	NULL
+/	NULL
c+	NULL
bp	NULL
242	NULL
201-	NULL
180	NULL
-	NULL
0	NULL
160	NULL
147	NULL
123-110	NULL
<	NULL
-	NULL
TSS	NULL
D	NULL
90	NULL
-	NULL
«	NULL
-	NULL
TSS	NULL
C	NULL
76	NULL
67	NULL
-	NULL
t	NULL
<	NULL
-	NULL
TSS	NULL
B	NULL
«	NULL
<	NULL
-	NULL
TSS	NULL
A	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
LAL	NULL
transcription	NULL
start	NULL
sites	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

The	NULL
autoradiograph	NULL
from	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
using	NULL
two	NULL
overlapping	NULL
RNA	NULL
probes	NULL
,	NULL
PAl	NULL
and	NULL
PAZ	NULL
spanning	NULL
from	NULL
nucleotides	NULL
-219	NULL
to	NULL
+59	NULL
and	NULL
-109	NULL
to	NULL
+59	NULL
,	NULL
respectively	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
contain	NULL
the	NULL
undigested	NULL
probes	NULL
,	NULL
yeasttRNA	NULL
was	NULL
used	NULL
as	NULL
negative	NULL
control	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Ten	NULL
jg	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
24-4	NULL
incubated	NULL
THP-1	NULL
cells	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
were	NULL
hybridized	NULL
to	NULL
probe	NULL
PAl	NULL
.	NULL

Lanes	NULL
6	NULL
and	NULL
8	NULL
contain	NULL
the	NULL
same	NULL
as	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
hybridized	NULL
to	NULL
probe	NULL
PAZ	NULL
.	NULL

The	NULL
protected	NULL
fragments	NULL
of	NULL
59	NULL
bp	NULL
,	NULL
62	NULL
bp	NULL
,	NULL
85	NULL
bp	NULL
,	NULL
and	NULL
95	NULL
bp	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
use	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
PMA-stimulated	NULL
THP-1	NULL
cells	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
plus	NULL
(	NULL
+	NULL
)	NULL
;	NULL
minus	NULL
(	NULL
-	NULL
)	NULL
refers	NULL
to	NULL
total	NULL
RNA	NULL
from	NULL
non-PMA-stimu-lated	NULL
cells	NULL
.	NULL

ing	NULL
and	NULL
PMAtreated	NULL
THP-1	NULL
cells	NULL
or	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Two	NULL
strong	NULL
signals	NULL
(	NULL
TSS	NULL
A	NULL
,	NULL
59	NULL
bp	NULL
;	NULL
TSS	NULL
B	NULL
,	NULL
62	NULL
bp	NULL
)	NULL
and	NULL
two	NULL
weak	NULL
signals	NULL
(	NULL
TSS	NULL
C	NULL
and	NULL
TSS	NULL
D	NULL
)	NULL
have	NULL
been	NULL
generated	NULL
with	NULL
either	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
indicating	NULL
major	NULL
and	NULL
minor	NULL
transcription	NULL
start	NULL
points	NULL
.	NULL

Such	NULL
a	NULL
preference	NULL
is	NULL
typical	NULL
for	NULL
TATAJless	NULL
and	NULL
(	NULL
G	NULL
+	NULL
C	NULL
)	NULL
-rich	NULL
promoters	NULL
(	NULL
28	NULL
)	NULL
.	NULL

As	NULL
all	NULL
protected	NULL
fragments	NULL
generated	NULL
with	NULL
the	NULL
shorter	NULL
PAZ	NULL
probe	NULL
are	NULL
also	NULL
generated	NULL
with	NULL
the	NULL
longer	NULL
PAl	NULL
probe	NULL
,	NULL
further	NULL
upstream	NULL
initiation	NULL
sites	NULL
can	NULL
be	NULL
excluded	NULL
.	NULL

Transcriptional	NULL
activity	NULL
from	NULL
the	NULL
two	NULL
major	NULL
initiation	NULL
sites	NULL
is	NULL
markedly	NULL
up-regulated	NULL
in	NULL
THP-1	NULL
cells	NULL
after	NULL
incubation	NULL
in	NULL
PMA	NULL
.	NULL

5'-Deletion	NULL
analysis	NULL
of	NULL
the	NULL
LAL	NULL
promoter	NULL
To	NULL
identify	NULL
sequences	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
,	NULL
seven	NULL
LAL	NULL
promoter	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
fusing	NULL
DNA	NULL
fragments	NULL
,	NULL
containing	NULL
sequential	NULL
5	NULL
truncations	NULL
of	NULL
the	NULL
putative	NULL
LAL	NULL
promoter	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
re	NULL
Ries	NULL
e	NULL
al	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
by	NULL
Spl	NULL
and	NULL
Ap-2	NULL
2129	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
A	NULL
Spi	NULL
AP2	NULL
Spi	NULL
Spi	NULL
-	NULL
NFxB	NULL
Spt	NULL
AP-2	NULL
(	NULL
-208	NULL
)	NULL
(	NULL
A171	NULL
)	NULL
(	NULL
-140	NULL
)	NULL
(	NULL
114	NULL
)	NULL
.-	NULL
(	NULL
84	NULL
)	NULL
(	NULL
37	NULL
)	NULL
+10	NULL
(	NULL
+12	NULL
)	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
alda	NULL
ngs	NULL
50	NULL
100	NULL
*~*~*	NULL
200	NULL
~	NULL
-100	NULL
TTC	NULL
vi	NULL
+67	NULL
pLAL1	NULL
(	NULL
-35267	NULL
208/+67	NULL
162	NULL
o	NULL
pLAL4	NULL
(	NULL
-158/+67	NULL
)	NULL
pLALS	NULL
(	NULL
-133/+67	NULL
)	NULL
oe	NULL
pLAL6	NULL
(	NULL
107/67	NULL
)	NULL
___	NULL
pGL3	NULL
Basic	NULL
ooo	NULL
~	NULL
e	NULL
TSSB	NULL
TSSA	NULL
7	NULL
“	NULL
GCCCTCCCGACAAGGCAGACCAGGCCCCCTGCAGGTCCCCTATCCGCACCCC	NULL
-	NULL
|	NULL
40	NULL
30	NULL
20	NULL
40	NULL
+1	NULL
|	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
LAL	NULL
gene	NULL
by	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

A	NULL
:	NULL
Basal	NULL
promoter	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
each	NULL
re-LAL	NULL
.	NULL

.	NULL

porter	NULL
gene	NULL
construct	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
pSVB-gal	NULL
plasmid	NULL
and	NULL
cultured	NULL
B	NULL
Promoter	NULL
Stimulation	NULL
by	NULL
PMA	NULL
for	NULL
48	NULL
h.	NULL
Aliquots	NULL
of	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-1	NULL
g	NULL
(	NULL
15	NULL
4	NULL
galactosidase	NULL
activity	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
re-	NULL
!	NULL

sults	NULL
were	NULL
normalized	NULL
in	NULL
respect	NULL
to	NULL
the	NULL
B-galactosidase	NULL
expression	NULL
.	NULL

pLAL1	NULL
_	NULL
The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
luciferase	NULL
activity/	NULL
B-galactosidase	NULL
activity	NULL
+	NULL
SE	NULL
from	NULL
5	NULL
independent	NULL
experiments	NULL
with	NULL
the	NULL
pLAL3	NULL
con-pLAL2	NULL
J	NULL
struct	NULL
being	NULL
set	NULL
to	NULL
a	NULL
value	NULL
of	NULL
100	NULL
.	NULL

Putative	NULL
cis-acting	NULL
consensus	NULL
se-pLAL3	NULL
.	NULL

quences	NULL
are	NULL
denoted	NULL
by	NULL
boxes	NULL
and	NULL
numbers	NULL
indicate	NULL
their	NULL
position	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
A.	NULL
DNA	NULL
sequence	NULL
at	NULL
pLAL4	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
is	NULL
depicted	NULL
at	NULL
the	NULL
bot-pLALS	NULL
tom	NULL
.	NULL

B	NULL
:	NULL
Effect	NULL
of	NULL
PMA	NULL
on	NULL
promoter	NULL
activity	NULL
of	NULL
different	NULL
LAL	NULL
promoter	NULL
constructs	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pLALG	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
various	NULL
LAL-luciferase	NULL
constructs	NULL
and	NULL
2	NULL
jg	NULL
pSVB-gal	NULL
LAL7	NULL
plasmid	NULL
for	NULL
24	NULL
h.	NULL
Luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
mea-p	NULL
porter	NULL
gene	NULL
.	NULL

The	NULL
deletions	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
range	NULL
from	NULL
-352	NULL
bp	NULL
to	NULL
-82	NULL
bp	NULL
in	NULL
regard	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
A.	NULL
Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
LAL	NULL
promoter	NULL
was	NULL
quantified	NULL
by	NULL
measuring	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
transiently	NULL
transfected	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

While	NULL
the	NULL
three	NULL
promoter	NULL
truncations	NULL
pLALl	NULL
,	NULL
pLAL2	NULL
,	NULL
and	NULL
pLAL3	NULL
result	NULL
in	NULL
similar	NULL
activities	NULL
,	NULL
the	NULL
larger	NULL
truncation	NULL
in	NULL
pLAL4	NULL
and	NULL
pLALS	NULL
revealed	NULL
only	NULL
60	NULL
%	NULL
activity	NULL
and	NULL
promoter	NULL
activity	NULL
is	NULL
nearly	NULL
abolished	NULL
in	NULL
the	NULL
shortest	NULL
promoter	NULL
constructs	NULL
pLAL6	NULL
and	NULL
pLAL7	NULL
.	NULL

In	NULL
the	NULL
THP-1	NULL
cell	NULL
line	NULL
,	NULL
all	NULL
but	NULL
the	NULL
latter	NULL
two	NULL
constructs	NULL
retained	NULL
PMA-induced	NULL
promoter	NULL
activity	NULL
(	NULL
2.2	NULL
to	NULL
3.6-fold	NULL
,	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
values	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
increase	NULL
in	NULL
transcription	NULL
rates	NULL
found	NULL
in	NULL
the	NULL
nuclear	NULL
run-on	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Co-transfection	NULL
with	NULL
Sp1	NULL
and	NULL
AP-2	NULL
expression	NULL
vectors	NULL
The	NULL
DNA	NULL
region	NULL
exhibiting	NULL
PMA-inducible	NULL
promoter	NULL
activity	NULL
has	NULL
been	NULL
localized	NULL
between	NULL
nucleotides	NULL
-107	NULL
and	NULL
-182	NULL
.	NULL

Several	NULL
putative	NULL
cis-acting	NULL
consensus	NULL
sequences	NULL
are	NULL
present	NULL
within	NULL
this	NULL
LAL	NULL
promoter	NULL
region	NULL
.	NULL

One	NULL
AP-2	NULL
site	NULL
is	NULL
located	NULL
at	NULL
position	NULL
-179	NULL
to	NULL
-171	NULL
and	NULL
AP-2	NULL
sites	NULL
are	NULL
known	NULL
to	NULL
be	NULL
phorbol	NULL
ester-inducible	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
are	NULL
two	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
2130	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
sured	NULL
in	NULL
cellular	NULL
extracts	NULL
.	NULL

The	NULL
normalized	NULL
luciferase	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
was	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
,	NULL
and	NULL
the	NULL
PMA	NULL
stimulation	NULL
factor	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
5	NULL
independent	NULL
experiments	NULL
of	NULL
triplicate	NULL
measurements	NULL
.	NULL

transcription	NULL
factor	NULL
Spl	NULL
at	NULL
positions	NULL
-146	NULL
to	NULL
-140	NULL
and	NULL
-120	NULL
to	NULL
-114	NULL
.	NULL

In	NULL
order	NULL
to	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
these	NULL
putative	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
co-transfected	NULL
THP-1	NULL
cells	NULL
with	NULL
the	NULL
LAL	NULL
promoter	NULL
construct	NULL
pLAL3	NULL
and	NULL
expression	NULL
vectors	NULL
for	NULL
Spl	NULL
(	NULL
pPacSp1l	NULL
)	NULL
or	NULL
AP2a	NULL
(	NULL
pCMXAP2a	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
expression	NULL
of	NULL
Spl	NULL
or	NULL
AP-2	NULL
caused	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
LAL	NULL
promoter	NULL
activity	NULL
(	NULL
2.7-fold	NULL
,	NULL
and	NULL
1.8	NULL
-fold	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
involvement	NULL
of	NULL
both	NULL
transcription	NULL
factors	NULL
in	NULL
PMA-induced	NULL
up-regulation	NULL
of	NULL
LAL	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Simultaneous	NULL
transfection	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
Spl	NULL
and	NULL
AP-2	NULL
resulted	NULL
in	NULL
a	NULL
3.5-fold	NULL
increase	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
both	NULL
transcription	NULL
factors	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
modulate	NULL
LAL	NULL
promoter	NULL
activity	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
PMA-inducible	NULL
LAL	NULL
promoter	NULL
region	NULL
To	NULL
verify	NULL
whether	NULL
Spl	NULL
and	NULL
AP-2	NULL
are	NULL
indeed	NULL
components	NULL
of	NULL
the	NULL
binding	NULL
complex	NULL
responsible	NULL
for	NULL
the	NULL
inducibility	NULL
by	NULL
PMA	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
analyses	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
resting	NULL
or	NULL
PMA-treated	NULL
THP-1	NULL
cells	NULL
.	NULL

Three	NULL
doublestranded	NULL
oligonucleotides	NULL
,	NULL
GSAl	NULL
(	NULL
-218/	NULL
-168	NULL
)	NULL
,	NULL
GSAZ	NULL
(	NULL
-167/	NULL
-128	NULL
)	NULL
,	NULL
and	NULL
GSA3	NULL
(	NULL
-127/	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
44	NULL
[	NULL
Xpucis	NULL
[	NULL
]	NULL
Sp1	NULL
Cap	NULL
War2rspi	NULL
3	NULL
-I	NULL
2,5	NULL
>	NULL
5	NULL
<	NULL
T	NULL
$	NULL
_	NULL
Es	NULL
°	NULL
2	NULL
5	NULL
CL	NULL
%	NULL
<	NULL
*	NULL
©	NULL
a	NULL
©	NULL
17	NULL
[	NULL
+	NULL
]	NULL
€	NULL
pLAL	NULL
3	NULL
+	NULL
+	NULL
+	NULL
+	NULL
pPac§Sp1	NULL
~	NULL
+	NULL
=	NULL
+	NULL
pCMXAP-2a	NULL
-	NULL
=	NULL
+	NULL
+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Co-transfection	NULL
with	NULL
transcription	NULL
factor	NULL
expression	NULL
plas-mids	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pLAL3	NULL
promoter	NULL
construct	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
transcription	NULL
factor	NULL
expression	NULL
vectors	NULL
for	NULL
Spl	NULL
(	NULL
pPacSp1	NULL
)	NULL
,	NULL
AP2a	NULL
(	NULL
pCMXAP2	NULL
@	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
Sp1	NULL
and	NULL
AP-2	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
used	NULL
for	NULL
measurement	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
3	NULL
independent	NULL
experiments	NULL
with	NULL
triplicate	NULL
measurements	NULL
.	NULL

-88	NULL
)	NULL
,	NULL
were	NULL
radiolabeled	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
.	NULL

GSAl	NULL
bound	NULL
to	NULL
one	NULL
protein	NULL
complex	NULL
in	NULL
THP-1	NULL
cell	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Using	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
,	NULL
a	NULL
marked	NULL
increase	NULL
of	NULL
this	NULL
complex	NULL
I	NULL
was	NULL
observed	NULL
.	NULL

Additionally	NULL
,	NULL
a	NULL
second	NULL
protein	NULL
complex	NULL
(	NULL
I1	NULL
)	NULL
appeared	NULL
.	NULL

Complex	NULL
I	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
Spl	NULL
gene	NULL
product	NULL
based	NULL
on	NULL
interaction	NULL
with	NULL
anti-Spl	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

When	NULL
anti-AP2	NULL
antibodies	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
the	NULL
complex	NULL
II	NULL
was	NULL
retarded	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
formed	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
GSA1l	NULL
with	NULL
transcription	NULL
factor	NULL
AP-2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
to	NULL
oligonucleotide	NULL
GSA1	NULL
can	NULL
be	NULL
disrupted	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
THP-1	NULL
cellular	NULL
extract	NULL
with	NULL
unlabeled	NULL
GSAl	NULL
oligonucleotide	NULL
in	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
transcription	NULL
factor	NULL
PU.1	NULL
caused	NULL
no	NULL
specific	NULL
supershift	NULL
of	NULL
the	NULL
complex	NULL
pattern	NULL
.	NULL

Incubation	NULL
of	NULL
probes	NULL
GSA2	NULL
and	NULL
GSA3	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
one	NULL
major	NULL
protein	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
this	NULL
complex	NULL
(	NULL
I	NULL
)	NULL
is	NULL
markedly	NULL
increased	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMAtreated	NULL
THP-1	NULL
cells	NULL
are	NULL
used	NULL
.	NULL

Antibodies	NULL
specific	NULL
to	NULL
Spl	NULL
transcription	NULL
factor	NULL
incubated	NULL
with	NULL
the	NULL
reaction	NULL
mixture	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
complex	NULL
I	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
new	NULL
complex	NULL
with	NULL
high	NULL
molecular	NULL
weight	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Sp1	NULL
binds	NULL
to	NULL
both	NULL
oligonucleotides	NULL
GSA2	NULL
and	NULL
GSA3	NULL
.	NULL

Preincubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
antibodies	NULL
against	NULL
PU.1	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
change	NULL
in	NULL
the	NULL
complex	NULL
pattern	NULL
using	NULL
GSA3	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Addition	NULL
of	NULL
antibodies	NULL
against	NULL
PU.1	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
with	NULL
GSAZ	NULL
resulted	NULL
in	NULL
a	NULL
faster	NULL
migrating	NULL
complex	NULL
of	NULL
unknown	NULL
origin	NULL
.	NULL

Antibodies	NULL
against	NULL
AP2	NULL
did	NULL
not	NULL
change	NULL
the	NULL
complex	NULL
pattern	NULL
with	NULL
GSAZ	NULL
and	NULL
GSA3	NULL
.	NULL

Speci-ficity	NULL
of	NULL
the	NULL
Spl	NULL
or	NULL
AP-2	NULL
interaction	NULL
with	NULL
the	NULL
respective	NULL
DNA	NULL
sequences	NULL
was	NULL
demonstrated	NULL
by	NULL
competition	NULL
experiments	NULL
using	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
non-Jlabeled	NULL
doublestranded	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
characterized	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
.	NULL

As	NULL
a	NULL
cellular	NULL
model	NULL
we	NULL
used	NULL
the	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
which	NULL
upon	NULL
specific	NULL
stimulation	NULL
can	NULL
differentiate	NULL
to	NULL
a	NULL
macrophage	NULL
like	NULL
state	NULL
thus	NULL
mimicking	NULL
monocyte/	NULL
macrophage	NULL
differentiation	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
phorbol	NULL
esters	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
stimulate	NULL
monocytic	NULL
differentiation	NULL
(	NULL
13	NULL
)	NULL
,	NULL
do	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
mRNA	NULL
transcripts	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
LAL	NULL
mRNA	NULL
resulted	NULL
in	NULL
higher	NULL
amounts	NULL
of	NULL
LAL	NULL
enzyme	NULL
within	NULL
the	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
LAL	NULL
mRNA	NULL
is	NULL
mostly	NULL
due	NULL
to	NULL
strong	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
additional	NULL
posttranscriptional	NULL
mechanisms	NULL
like	NULL
mRNA	NULL
stability	NULL
appear	NULL
to	NULL
contribute	NULL
to	NULL
differentiation	NULL
-dependent	NULL
increase	NULL
in	NULL
LAL	NULL
mRNA	NULL
.	NULL

The	NULL
LAL	NULL
promoter	NULL
region	NULL
is	NULL
(	NULL
G	NULL
+	NULL
C	NULL
)	NULL
-rich	NULL
and	NULL
lacks	NULL
a	NULL
classical	NULL
TATAbox	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
multiple	NULL
transcription	NULL
start	NULL
points	NULL
was	NULL
not	NULL
surprising	NULL
(	NULL
28	NULL
)	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
certain	NULL
other	NULL
TATAJless	NULL
housekeeping	NULL
promoters	NULL
,	NULL
the	NULL
LAL	NULL
promoter	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
differentia-tion-dependent	NULL
manner	NULL
.	NULL

Using	NULL
deletion	NULL
derivatives	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
the	NULL
minimal	NULL
PMA-inducible	NULL
promoter	NULL
sequence	NULL
has	NULL
been	NULL
identified	NULL
between	NULL
nucleotides	NULL
-107	NULL
and	NULL
-182	NULL
.	NULL

Within	NULL
this	NULL
76-bp	NULL
promoter	NULL
region	NULL
one	NULL
AP-2-like	NULL
consensus	NULL
sequence	NULL
is	NULL
present	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-2	NULL
is	NULL
subject	NULL
to	NULL
distinct	NULL
regulatory	NULL
mechanisms	NULL
.	NULL

Phorbol	NULL
esters	NULL
and	NULL
signals	NULL
that	NULL
elevate	NULL
cyclic	NULL
AMP	NULL
concentration	NULL
have	NULL
been	NULL
found	NULL
to	NULL
induce	NULL
AP-2	NULL
activity	NULL
without	NULL
affecting	NULL
AP-2	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
an	NULL
alternatively	NULL
spliced	NULL
AP-2	NULL
gene	NULL
product	NULL
may	NULL
negatively	NULL
regulate	NULL
AP-2	NULL
activity	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
AP-2	NULL
site	NULL
,	NULL
we	NULL
found	NULL
two	NULL
Spl	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
PMA-responsive	NULL
region	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
promoter	NULL
.	NULL

Spl	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
TATA-box	NULL
binding	NULL
protein	NULL
(	NULL
TBP	NULL
)	NULL
-associated	NULL
protein	NULL
TAF	NULL
110	NULL
and	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
another	NULL
TBP	NULL
-associated	NULL
protein	NULL
,	NULL
TAF	NULL
250	NULL
,	NULL
activate	NULL
transcription	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Spl	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
many	NULL
TATA-less	NULL
promoters	NULL
and	NULL
may	NULL
function	NULL
to	NULL
recruit	NULL
or	NULL
stabilize	NULL
the	NULL
TFIID	NULL
initiation	NULL
complex	NULL
via	NULL
a	NULL
``	NULL
tethering	NULL
factor	NULL
``	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
Sp1	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
its	NULL
role	NULL
in	NULL
cell-specific	NULL
and	NULL
regulation	NULL
processes	NULL
has	NULL
been	NULL
implicated	NULL
(	NULL
35-37	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
TATAdess	NULL
promoters	NULL
of	NULL
the	NULL
myeloid	NULL
specific	NULL
integrin	NULL
CD11b	NULL
(	NULL
36	NULL
)	NULL
,	NULL
the	NULL
monocyte	NULL
specific	NULL
gene	NULL
CD14	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
the	NULL
neural	NULL
specific	NULL
acetylcholine	NULL
receptor	NULL
a	NULL
;	NULL
gene	NULL
(	NULL
38	NULL
)	NULL
have	NULL
been	NULL
analyzed	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
these	NULL
two	NULL
transcription	NULL
fac-	NULL
Ries	NULL
e	NULL
al	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
by	NULL
Spl	NULL
and	NULL
Ap-2	NULL
2131	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
A	NULL
B	NULL
GSA2	NULL
GSA1	NULL
C	NULL
pess	NULL
i	NULL
=O	NULL
|	NULL
-	NULL
2	NULL
)	NULL
PU	NULL
.	NULL

antibody	NULL
!	NULL

-	NULL
|	NULL
-	NULL
|	NULL
Sp1|AP-2	NULL
]	NULL
PU	NULL
zEﬁOdy	NULL
-	NULL
|	NULL
+	NULL
8:31	NULL
A12	NULL
P11	NULL
PMA	NULL
=	NULL
+	NULL
[	NULL
+	NULL
|	NULL
+	NULL
antibody|	NULL
-	NULL
_—___S	NULL
;	NULL
1|AP.Q	NULL
PUA	NULL
lane	NULL
1	NULL
2	NULL
|	NULL
3	NULL
4	NULL
|	NULL
5	NULL
lane	NULL
1	NULL
3	NULL
4	NULL
|	NULL
5	NULL
[	NULL
PMA	NULL
-	NULL
|	NULL
4	NULL
7L	NULL
“	NULL
.	NULL

+	NULL
]	NULL
lane	NULL
1	NULL
2	NULL
3	NULL
|	NULL
4	NULL
|	NULL
s	NULL
®	NULL
*	NULL
ga	NULL
1	NULL
%	NULL
_	NULL
]	NULL
SP1	NULL
pet	NULL
H	NULL
7	NULL
]	NULL
sP1	NULL
p	NULL
1	NULL
-	NULL
|i	NULL
gans	NULL
j	NULL
bt	NULL
-	NULL
twWid	NULL
_.	NULL
Te	NULL
II	NULL
probe	NULL
*	NULL
probe	NULL
free	NULL
probeﬁ	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
and	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
PMA-responsive	NULL
element	NULL
in	NULL
the	NULL
LAL	NULL
promoter	NULL
.	NULL

A	NULL
:	NULL
GSAl	NULL
(	NULL
-218/	NULL
168	NULL
)	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
extract	NULL
from	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Sp1-antibodies	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-2-antibodies	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.l-antibodies	NULL
.	NULL

B	NULL
:	NULL
GSAZ	NULL
(	NULL
-167/	NULL
-128	NULL
)	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
extract	NULL
from	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Spl-antibodies	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-2-antibodies	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.1-antibodies	NULL
.	NULL

C	NULL
:	NULL
GSA3	NULL
(	NULL
-127/	NULL
-88	NULL
)	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
extract	NULL
from	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Spl-antibodies	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-Z-antibodies	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.1-antibodies	NULL
.	NULL

Brackets	NULL
to	NULL
the	NULL
right	NULL
indicate	NULL
the	NULL
specific	NULL
supershifted	NULL
complexes	NULL
.	NULL

Arrows	NULL
to	NULL
the	NULL
left	NULL
indicate	NULL
complexes	NULL
in	NULL
induced	NULL
nuclear	NULL
extracts	NULL
.	NULL

tors	NULL
,	NULL
AP-2	NULL
and	NULL
Spl	NULL
,	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
phorbol	NULL
estermediated	NULL
expression	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
AP-2	NULL
site	NULL
(	NULL
-171	NULL
)	NULL
decreased	NULL
both	NULL
basal	NULL
and	NULL
PMA-enhanced	NULL
promoter	NULL
activity	NULL
by	NULL
40	NULL
%	NULL
.	NULL

Elimination	NULL
of	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
-140	NULL
)	NULL
did	NULL
not	NULL
further	NULL
suppress	NULL
promoter	NULL
function	NULL
,	NULL
whereas	NULL
deletion	NULL
of	NULL
the	NULL
second	NULL
Sp1	NULL
site	NULL
(	NULL
-114	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
almost	NULL
complete	NULL
elimination	NULL
of	NULL
both	NULL
basal	NULL
and	NULL
PMA-induced	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
order	NULL
to	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Spl	NULL
and	NULL
AP-2	NULL
sites	NULL
in	NULL
LAL	NULL
gene	NULL
transcription	NULL
,	NULL
we	NULL
analyzed	NULL
LAL	NULL
promoter	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
after	NULL
co-transfection	NULL
with	NULL
Spl	NULL
and	NULL
AP2	NULL
expression	NULL
plasmids	NULL
and	NULL
an	NULL
LAL	NULL
promoter/	NULL
luciferase	NULL
construct	NULL
.	NULL

Cotransfection	NULL
of	NULL
Spl	NULL
with	NULL
the	NULL
shortest	NULL
fully	NULL
inducible	NULL
LAL	NULL
promoter	NULL
construct	NULL
pLAL3	NULL
resulted	NULL
in	NULL
a	NULL
2.7-fold	NULL
augmentation	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

Co-transfection	NULL
of	NULL
AP2	NULL
expression	NULL
vector	NULL
also	NULL
increased	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
pLAL3	NULL
(	NULL
-182/	NULL
+67	NULL
)	NULL
con-struct	NULL
,	NULL
but	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
(	NULL
1.8-fold	NULL
)	NULL
.	NULL

Simultaneous	NULL
transfection	NULL
of	NULL
THP	NULL
-1	NULL
cells	NULL
with	NULL
Sp1	NULL
and	NULL
AP-2	NULL
led	NULL
to	NULL
a	NULL
3.5-fold	NULL
increase	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
experiments	NULL
indicate	NULL
that	NULL
Spl	NULL
and	NULL
AP-2	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
enhance	NULL
LAL	NULL
transcription	NULL
.	NULL

2132	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
Using	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
PMA	NULL
treatment	NULL
of	NULL
THP-1	NULL
cells	NULL
led	NULL
to	NULL
an	NULL
increased	NULL
binding	NULL
of	NULL
several	NULL
nuclear	NULL
factors	NULL
to	NULL
labeled	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
PMA-responsive	NULL
LAL	NULL
promoter	NULL
region	NULL
.	NULL

Binding	NULL
activities	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
responsible	NULL
for	NULL
PMA	NULL
inducibility	NULL
have	NULL
been	NULL
characterized	NULL
as	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
by	NULL
experiments	NULL
using	NULL
specific	NULL
antibod-ies	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
AP-2	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
Spl	NULL
in	NULL
PMA-mediated	NULL
transcriptional	NULL
regulation	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
,	NULL
Biggs	NULL
,	NULL
Kudlow	NULL
,	NULL
and	NULL
Kraft	NULL
(	NULL
39	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
Spl	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
PMA-induced	NULL
expression	NULL
of	NULL
the	NULL
WAF1/	NULL
CIP1-gene	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

They	NULL
demonstrated	NULL
that	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
multiple	NULL
Spl	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
TATA-box	NULL
is	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
.	NULL

D'Angelo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
reported	NULL
that	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
is	NULL
enhanced	NULL
by	NULL
PMA	NULL
due	NULL
to	NULL
increased	NULL
Spl	NULL
protein	NULL
levels	NULL
and	NULL
Spl	NULL
binding	NULL
to	NULL
a	NULL
C-rich	NULL
element	NULL
.	NULL

To	NULL
prove	NULL
whether	NULL
Spl	NULL
protein	NULL
levels	NULL
increase	NULL
during	NULL
PMA	NULL
treatment	NULL
of	NULL
THP-1	NULL
cells	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
immunoblots	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
and	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
Spl	NULL
protein	NULL
was	NULL
significantly	NULL
higher	NULL
in	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
compared	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
to	NULL
resting	NULL
THP-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
and	NULL
our	NULL
results	NULL
demonstrating	NULL
the	NULL
necessity	NULL
of	NULL
protein	NULL
synthesis	NULL
for	NULL
PMAenhanced	NULL
LAL	NULL
gene	NULL
expression	NULL
suggest	NULL
that	NULL
induction	NULL
is	NULL
partially	NULL
mediated	NULL
by	NULL
an	NULL
increased	NULL
Spl	NULL
synthesis	NULL
and	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
in	NULL
a	NULL
differentiation-dependent	NULL
manner	NULL
.	NULL

In	NULL
recent	NULL
studies	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
Spl	NULL
expression	NULL
itself	NULL
is	NULL
regulated	NULL
.	NULL

Thus	NULL
Spl	NULL
levels	NULL
decrease	NULL
during	NULL
myo-genesis	NULL
,	NULL
which	NULL
contributes	NULL
to	NULL
the	NULL
repression	NULL
of	NULL
GLUTI	NULL
gene	NULL
transcription	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Spl	NULL
binding	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
maximal	NULL
PMA	NULL
enhancement	NULL
of	NULL
LAL	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
the	NULL
response	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
to	NULL
PMA	NULL
may	NULL
involve	NULL
interactions	NULL
of	NULL
Spl	NULL
and	NULL
AP2	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
that	NULL
Spl	NULL
interacts	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
like	NULL
Egr-1	NULL
(	NULL
PDGF-expression	NULL
)	NULL
,	NULL
AP2	NULL
{	NULL
acetylcholine	NULL
receptor	NULL
a	NULL
;	NULL
gene	NULL
expression	NULL
)	NULL
,	NULL
or	NULL
YYl	NULL
(	NULL
38	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
under	NULL
some	NULL
circumstances	NULL
Spl	NULL
can	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
or	NULL
modulator	NULL
independent	NULL
of	NULL
its	NULL
action	NULL
in	NULL
transcriptional	NULL
ini-tiation	NULL
.	NULL

Phosphorylation	NULL
and	NULL
glycosylation	NULL
of	NULL
Spl	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
variable	NULL
modes	NULL
of	NULL
regulation	NULL
of	NULL
promoter	NULL
activity	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
results	NULL
of	NULL
our	NULL
study	NULL
indicate	NULL
:	NULL
1	NULL
)	NULL
induction	NULL
of	NULL
LAL	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
THP-1	NULL
depends	NULL
on	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
and	NULL
new	NULL
protein	NULL
synthesis	NULL
;	NULL
2	NULL
)	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP2	NULL
may	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
enhance	NULL
transcription	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
after	NULL
PMA	NULL
treatment	NULL
;	NULL
and	NULL
3	NULL
)	NULL
LAL	NULL
activity	NULL
is	NULL
partly	NULL
regulated	NULL
by	NULL
posttranscriptional	NULL
mechanisms	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
far	NULL
from	NULL
being	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
``	NULL
housekeeping	NULL
``	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
is	NULL
a	NULL
dynamically	NULL
regulated	NULL
enhancer	NULL
playing	NULL
a	NULL
critical	NULL
regulatory	NULL
role	NULL
for	NULL
numerous	NULL
genes	NULL
.	NULL

In	NULL
the	NULL
future	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
potential	NULL
Spl	NULL
binding	NULL
sites	NULL
in	NULL
other	NULL
monocytic	NULL
genes	NULL
also	NULL
contribute	NULL
to	NULL
specific	NULL
regulation	NULL
during	NULL
the	NULL
monocyte/	NULL
macrophage	NULL
differentiation	NULL
process	NULL
.	NULL

B	NULL
We	NULL
thank	NULL
Dr.	NULL
Robert	NULL
Tjian	NULL
for	NULL
the	NULL
pPac§pl	NULL
expression	NULL
construct	NULL
and	NULL
Dr.	NULL
Reinhard	NULL
Buettner	NULL
for	NULL
the	NULL
pCMXAP2	NULL
«	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
authors	NULL
thank	NULL
Dr.	NULL
Jaime	NULL
Eduardo	NULL
Ramirez-Vick	NULL
for	NULL
helpful	NULL
comments	NULL
.	NULL

The	NULL
technical	NULL
assistance	NULL
of	NULL
Renate	NULL
Glatzl	NULL
is	NULL
appreciated	NULL
.	NULL

Part	NULL
of	NULL
this	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
within	NULL
the	NULL
Forschergruppe	NULL
``	NULL
Molekulare	NULL
Grundlagen	NULL
der	NULL
Differenzierung	NULL
und	NULL
Aktivierung	NULL
mononuklei	NULL
#	NULL
rer	NULL
Phagozyten	NULL
``	NULL
(	NULL
AN	NULL
111/	NULL
6-1	NULL
)	NULL
.	NULL

Manuscript	NULL
received	NULL
11	NULL
March	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
29	NULL
June	NULL
1998	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Goldstein	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Brown	NULL
.	NULL

1977	NULL
.	NULL

The	NULL
low-density	NULL
lipoprotein	NULL
pathway	NULL
and	NULL
its	NULL
relation	NULL
to	NULL
atherosclerosis	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

46	NULL
:	NULL
897-930	NULL
.	NULL

2	NULL
.	NULL

Stary	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Chandler	NULL
,	NULL
S.	NULL
Glagoy	NULL
,	NULL
J.	NULL
R.	NULL
Guyton	NULL
,	NULL
W.	NULL
Insull	NULL
,	NULL
M.	NULL
E.	NULL
Rosenfeld	NULL
,	NULL
S.	NULL
A.	NULL
Schaffer	NULL
,	NULL
C.	NULL
J.	NULL
Schwartz	NULL
,	NULL
W.	NULL
D.	NULL
Wagner	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Wissler	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
definition	NULL
of	NULL
initial	NULL
,	NULL
fatty	NULL
streak	NULL
,	NULL
and	NULL
intermediate	NULL
lesions	NULL
of	NULL
atherosclerosis	NULL
.	NULL

Arterioscler	NULL
Thromb	NULL
.	NULL

14	NULL
:	NULL
840-856	NULL
.	NULL

3	NULL
.	NULL

Coates	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
T.	NULL
Langer	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Cortner	NULL
.	NULL

1986	NULL
.	NULL

Genetic	NULL
variation	NULL
of	NULL
human	NULL
mononuclear	NULL
leukocyte	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
activity	NULL
.	NULL

Relationship	NULL
to	NULL
atherosclerosis	NULL
.	NULL

Atherosclerosis	NULL
.	NULL

62	NULL
:	NULL
11-20	NULL
.	NULL

4	NULL
.	NULL

Yatsu	NULL
,	NULL
F	NULL
M.	NULL
,	NULL
F	NULL
C.	NULL
Hagemenas	NULL
,	NULL
L.	NULL
C.	NULL
Manaugh	NULL
,	NULL
and	NULL
T.	NULL
Galambos	NULL
.	NULL

Ries	NULL
e	NULL
al	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

1980	NULL
.	NULL

Cholesteryl	NULL
ester	NULL
hydrolase	NULL
activity	NULL
in	NULL
human	NULL
symptomatic	NULL
atherosclerosis	NULL
.	NULL

Lipids	NULL
.	NULL

15	NULL
:	NULL
1019-1022.	NULL
.	NULL

Schmitz	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
G.	NULL
Assmann	NULL
.	NULL

1989	NULL
.	NULL

Acid	NULL
lipase	NULL
deficiency	NULL
:	NULL
Wol-	NULL
man	NULL
disease	NULL
and	NULL
cholesteryl	NULL
ester	NULL
storage	NULL
disease	NULL
.	NULL

In	NULL
The	NULL
Metabolic	NULL
Basis	NULL
of	NULL
Inherited	NULL
Disease	NULL
.	NULL

C.	NULL
R.	NULL
Scriver	NULL
,	NULL
A.	NULL
L.	NULL
Beaudet	NULL
,	NULL
W.	NULL
S.	NULL
Sly	NULL
,	NULL
and	NULL
D.	NULL
Valle	NULL
,	NULL
editors	NULL
.	NULL

MacGraw-	NULL
Hill	NULL
,	NULL
New	NULL
York	NULL
.	NULL

1623-1644.	NULL
.	NULL

Klima	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Ullrich	NULL
,	NULL
C.	NULL
Aslanidis	NULL
,	NULL
P.	NULL
Fehringer	NULL
,	NULL
K.	NULL
J.	NULL
Lackner	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
splice	NULL
junction	NULL
mutation	NULL
causes	NULL
deletion	NULL
of	NULL
a	NULL
72-base	NULL
exon	NULL
from	NULL
the	NULL
mRNA	NULL
for	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
cholesteryl	NULL
ester	NULL
storage	NULL
disease	NULL
.	NULL

J	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92	NULL
:	NULL
2713-2718.	NULL
.	NULL

Aslanidis	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Ries	NULL
,	NULL
P.	NULL
Fehringer	NULL
,	NULL
C.	NULL
Buechler	NULL
,	NULL
H.	NULL
Klima	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

1996	NULL
.	NULL

Genetic	NULL
and	NULL
biochemical	NULL
evidence	NULL
that	NULL
CESD	NULL
and	NULL
Wolman	NULL
disease	NULL
are	NULL
distinguished	NULL
by	NULL
residual	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
activity	NULL
.	NULL

Genomics	NULL
.	NULL

331	NULL
85-93.	NULL
.	NULL

Ries	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Aslanidis	NULL
,	NULL
P.	NULL
Fehringer	NULL
,	NULL
J.	NULL
C.	NULL
Carel	NULL
,	NULL
D.	NULL
Gendrel	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
new	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
leads	NULL
to	NULL
Wolman	NULL
disease	NULL
in	NULL
an	NULL
African	NULL
kindred	NULL
.	NULL

J	NULL
Lipid	NULL
.	NULL

Res	NULL
.	NULL

37	NULL
:	NULL
1761-1765.	NULL
.	NULL

Anderson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Sando	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
cDNA	NULL
encoding	NULL
human	NULL
lysosomal	NULL
acid	NULL
lipase/	NULL
cholesteryl	NULL
ester	NULL
hydrolase	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
:	NULL
22479-22484	NULL
.	NULL

Aslanidis	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Klima	NULL
,	NULL
K.	NULL
J.	NULL
Lackner	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

1994	NULL
.	NULL

Genomic	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
lysosomal	NULL
acid	NULL
lipase	NULL
gene	NULL
(	NULL
LIPA	NULL
)	NULL
.	NULL

Genomics	NULL
.	NULL

20	NULL
:	NULL
329-331	NULL
.	NULL

Anderson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
S.	NULL
Byrum	NULL
,	NULL
P.	NULL
M.	NULL
Coates	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Sando	NULL
.	NULL

1994	NULL
.	NULL

Mutations	NULL
at	NULL
the	NULL
lysosomal	NULL
acid	NULL
cholesteryl	NULL
ester	NULL
hydrolase	NULL
gene	NULL
locus	NULL
in	NULL
Wolman	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

911	NULL
2718-2722	NULL
.	NULL

Gabig	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Babior	NULL
.	NULL

1981	NULL
.	NULL

The	NULL
killing	NULL
of	NULL
pathogenes	NULL
by	NULL
phagocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

32	NULL
:	NULL
313-326	NULL
.	NULL

Auwerx	NULL
,	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
:	NULL
a	NULL
multifaceted	NULL
model	NULL
for	NULL
the	NULL
study	NULL
of	NULL
monocyte-macrophage	NULL
differentiation	NULL
.	NULL

Experientia	NULL
.	NULL

47	NULL
:	NULL
22-31	NULL
.	NULL

Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
Y	NULL
Kobayashi	NULL
,	NULL
Y	NULL
Goto	NULL
,	NULL
H.	NULL
Okumura	NULL
,	NULL
S.	NULL
Nakae	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
and	NULL
K.	NULL
Tada	NULL
.	NULL

1982	NULL
.	NULL

Induction	NULL
of	NULL
maturation	NULL
in	NULL
cultured	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
a	NULL
phorbol	NULL
diester	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

42	NULL
:	NULL
1530-1536	NULL
.	NULL

Moulton	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
H.	NULL
Wu	NULL
,	NULL
J.	NULL
Barnett	NULL
,	NULL
S.	NULL
Parthasarathy	NULL
,	NULL
and	NULL
C.	NULL
K.	NULL
Glass	NULL
.	NULL

1992	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
acetylated	NULL
low	NULL
density	NULL
lipoprotein	NULL
receptor	NULL
gene	NULL
and	NULL
isolation	NULL
of	NULL
promoter	NULL
sequences	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89	NULL
:	NULL
8102-8106	NULL
.	NULL

Lee	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
D.	NULL
M.	NULL
Underhill	NULL
,	NULL
M.	NULL
K.	NULL
Crane	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Gluck	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
vacuolar	NULL
H	NULL
(	NULL
+	NULL
)	NULL
-ATPase	NULL
B2	NULL
sub-unit	NULL
gene	NULL
in	NULL
differentiating	NULL
THP-1	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chen	NULL
.	NULL

270	NULL
:	NULL
7320-7329	NULL
.	NULL

Atkins	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Troen	NULL
.	NULL

1995	NULL
.	NULL

Phorbol	NULL
esterstimulated	NULL
cathepsin	NULL
L	NULL
expression	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
6	NULL
:	NULL
713-718	NULL
.	NULL

Bauer	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
Hannig	NULL
.	NULL

1988	NULL
.	NULL

Countercurrent	NULL
centrifugal	NULL
elutra-tion	NULL
in	NULL
a	NULL
table-top	NULL
centrifuge	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

112	NULL
:	NULL
213-218	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Przybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
.	NULL

18	NULL
:	NULL
5294-5299	NULL
.	NULL

Srivastava	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
E.	NULL
E.	NULL
Cable	NULL
,	NULL
and	NULL
H.	NULL
L.	NULL
Bonkovsky	NULL
.	NULL

1993	NULL
.	NULL

Purifying	NULL
nascent	NULL
mRNA	NULL
from	NULL
nuclear	NULL
run-on	NULL
assays	NULL
using	NULL
guanidinium	NULL
isothiocyanate	NULL
.	NULL

Biotechniques	NULL
.	NULL

15	NULL
:	NULL
226-227	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
.	NULL

227	NULL
:	NULL
680-685	NULL
.	NULL

Smith	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
R.	NULL
I.	NULL
Krohn	NULL
,	NULL
G.	NULL
T.	NULL
Hermanson	NULL
,	NULL
A.	NULL
K.	NULL
Mallia	NULL
,	NULL
F.	NULL
H.	NULL
Gart-ner	NULL
,	NULL
M.	NULL
D.	NULL
Provenzano	NULL
,	NULL
E.	NULL
K.	NULL
Fujimoto	NULL
,	NULL
N.	NULL
M.	NULL
Goeke	NULL
,	NULL
B.	NULL
J.	NULL
Olson	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Klenk	NULL
.	NULL

1985	NULL
.	NULL

Measurement	NULL
of	NULL
protein	NULL
using	NULL
bicincho-ninic	NULL
acid	NULL
.	NULL

Anal	NULL
.	NULL

Biochen	NULL
.	NULL

150	NULL
:	NULL
76-85	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
P.	NULL
L.	NULL
Martin	NULL
,	NULL
B.	NULL
S.	NULL
Shastry	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Eukaryotic	NULL
gene	NULL
transcription	NULL
with	NULL
purified	NULL
components	NULL
.	NULL

M	NULL
&	NULL
éhods	NULL
Enzymol	NULL
.	NULL

1011	NULL
582-598	NULL
.	NULL

Sompayrac	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Danna	NULL
.	NULL

1981	NULL
.	NULL

Efficient	NULL
infection	NULL
of	NULL
monkey	NULL
cells	NULL
with	NULL
DNA	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sd	NULL
.	NULL

USA	NULL
.	NULL

781	NULL
7575-1578	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Basheeruddin	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Rechtoris	NULL
,	NULL
and	NULL
T.	NULL
Mazzone	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
and	NULL
posttranscriptional	NULL
control	NULL
of	NULL
apolipoprotein	NULL
E	NULL
gene	NULL
expression	NULL
in	NULL
differentiating	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

267	NULL
:	NULL
1219-1224	NULL
.	NULL

Horiguchi	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Sariban	NULL
,	NULL
and	NULL
D.	NULL
Kufe	NULL
.	NULL

1988	NULL
.	NULL

Transcriptional	NULL
and	NULL
posttran	NULL
scriptional	NULL
regulation	NULL
of	NULL
CSF-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
:	NULL
3951-3954	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LAL	NULL
gene	NULL
by	NULL
Spl	NULL
and	NULL
Ap-2	NULL
2133	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

2134	NULL
Ye	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Clark	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
human	NULL
interleukin	NULL
1	NULL
type	NULL
I	NULL
receptor	NULL
gene	NULL
:	NULL
multiple	NULL
initiation	NULL
sites	NULL
,	NULL
high	NULL
G+C	NULL
content	NULL
,	NULL
and	NULL
constitutive	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90	NULL
:	NULL
2295-2299	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
path-ways	NULL
:	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
.	NULL

51	NULL
:	NULL
251-260	NULL
.	NULL

Buettner	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Kannan	NULL
,	NULL
A.	NULL
Imhof	NULL
,	NULL
R.	NULL
Bauer	NULL
,	NULL
S.	NULL
O.	NULL
Yim	NULL
,	NULL
R.	NULL
Glock-shuber	NULL
,	NULL
M.	NULL
W.	NULL
Van	NULL
Dyke	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Tainsky	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
alternatively	NULL
spliced	NULL
mRNA	NULL
from	NULL
the	NULL
AP-2	NULL
gene	NULL
encodes	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
AP-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
4174-4185	NULL
.	NULL

Gill	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Pascal	NULL
,	NULL
Z.	NULL
H.	NULL
Tseng	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
glutamine-rich	NULL
hydrophobic	NULL
patch	NULL
in	NULL
transcription	NULL
factor	NULL
Spl	NULL
contacts	NULL
the	NULL
dTAFII110	NULL
component	NULL
of	NULL
the	NULL
Drosophila	NULL
TFIID	NULL
complex	NULL
and	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

91	NULL
:	NULL
192-196	NULL
.	NULL

Weinzierl	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
B.	NULL
D.	NULL
Dynlacht	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1993	NULL
.	NULL

Largest	NULL
sub-unit	NULL
of	NULL
Drosophila	NULL
transcription	NULL
factor	NULL
IID	NULL
directs	NULL
assembly	NULL
of	NULL
a	NULL
complex	NULL
containing	NULL
TBP	NULL
and	NULL
a	NULL
coactivator	NULL
.	NULL

Nature	NULL
362	NULL
:	NULL
511-517	NULL
.	NULL

Pugh	NULL
,	NULL
B.	NULL
E	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1990	NULL
.	NULL

Mechanisms	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
Sp1	NULL
:	NULL
evidence	NULL
for	NULL
coactivators	NULL
.	NULL

Cell	NULL
.	NULL

61	NULL
:	NULL
1187-1197	NULL
.	NULL

Pugh	NULL
,	NULL
B.	NULL
E	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

Transcription	NULL
from	NULL
a	NULL
TATA¥ess	NULL
promoter	NULL
requires	NULL
a	NULL
multisubunit	NULL
TFIID	NULL
complex	NULL
.	NULL

Gares	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
:	NULL
1935-1945	NULL
.	NULL

Wu	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
T.	NULL
T.	NULL
Chen	NULL
,	NULL
and	NULL
T.	NULL
T.	NULL
Sun	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
importance	NULL
of	NULL
an	NULL
Spl	NULL
and	NULL
an	NULL
NFkB-related	NULL
nuclear	NULL
protein	NULL
in	NULL
a	NULL
keratinocyte-specific	NULL
promoter	NULL
of	NULL
rabbit	NULL
K3	NULL
keratin	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

269	NULL
:	NULL
28450-28459	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
R.	NULL
J.	NULL
Scheibe	NULL
,	NULL
D.	NULL
E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Sp1	NULL
transcription	NULL
factor	NULL
binds	NULL
the	NULL
CD11b	NULL
promoter	NULL
specifically	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
my-eloid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
8230-8239	NULL
.	NULL

Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
39	NULL
,	NULL
1998	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
C.	NULL
J.	NULL
Hetherington	NULL
,	NULL
S.	NULL
Tan	NULL
,	NULL
S.	NULL
E.	NULL
Dziennis	NULL
,	NULL
D.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
H.	NULL
M.	NULL
Chen	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1994	NULL
.	NULL

Sp1	NULL
is	NULL
a	NULL
critical	NULL
factor	NULL
for	NULL
the	NULL
monocytic	NULL
specific	NULL
expression	NULL
of	NULL
human	NULL
CD14	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

269	NULL
:	NULL
11425-11434	NULL
.	NULL

Yang	NULL
,	NULL
X.	NULL
,	NULL
Fyodorov	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Deneris	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
analysis	NULL
of	NULL
acetylcholine	NULL
receptor	NULL
alpha	NULL
3	NULL
gene	NULL
promoter	NULL
motifs	NULL
that	NULL
bind	NULL
Sp1	NULL
and	NULL
AP-2	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
8514-8520	NULL
.	NULL

Biggs	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
J.	NULL
E.	NULL
Kudlow	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Kraft	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
WAF1/	NULL
CIP1	NULL
gene	NULL
in	NULL
U937	NULL
leukemic	NULL
cells	NULL
.	NULL

Z	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

271	NULL
:	NULL
901-906	NULL
.	NULL

D'Angelo	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
B.	NULL
G.	NULL
Oliver	NULL
,	NULL
M.	NULL
G.	NULL
Davis	NULL
,	NULL
T.	NULL
S.	NULL
McCluskey	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Dorn	NULL
.	NULL

1996	NULL
.	NULL

Novel	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
phorbol	NULL
ester	NULL
enhancement	NULL
of	NULL
human	NULL
platelet	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2711	NULL
:	NULL
19696-19704	NULL
.	NULL

Vinals	NULL
,	NULL
E	NULL
,	NULL
C.	NULL
Fandos	NULL
,	NULL
T.	NULL
Santalucia	NULL
,	NULL
J.	NULL
Ferre	NULL
,	NULL
X.	NULL
Testar	NULL
,	NULL
M.	NULL
Palacin	NULL
,	NULL
and	NULL
A.	NULL
Zorzano	NULL
.	NULL

1997	NULL
.	NULL

Myogenesis	NULL
and	NULL
MyoD	NULL
down-regulate	NULL
Sp1	NULL
.	NULL

A	NULL
mechanism	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
GLUT1	NULL
during	NULL
muscle	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
:	NULL
12913-12921	NULL
.	NULL

Shingu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
P.	NULL
Bornstein	NULL
.	NULL

1994	NULL
.	NULL

Overlapping	NULL
Egr-1	NULL
and	NULL
Spl	NULL
sites	NULL
function	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
mouse	NULL
thrombospondin	NULL
1	NULL
gene	NULL
.	NULL

Z	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

269	NULL
:	NULL
32551-32557	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
K.	NULL
M.	NULL
Galvin	NULL
,	NULL
and	NULL
Y	NULL
Shi	NULL
.	NULL

1993	NULL
.	NULL

Evidence	NULL
for	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
zincifinger	NULL
transcription	NULL
factors	NULL
YYl	NULL
and	NULL
Sp1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

901	NULL
6145-6149	NULL
.	NULL

Schaufele	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
L.	NULL
West	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Reudelhuber	NULL
.	NULL

1992	NULL
.	NULL

Overlapping	NULL
Pit-l	NULL
and	NULL
Spl	NULL
binding	NULL
sites	NULL
are	NULL
both	NULL
essential	NULL
to	NULL
full	NULL
rat	NULL
growth	NULL
hormone	NULL
gene	NULL
promoter	NULL
activity	NULL
despite	NULL
mutually	NULL
exclusive	NULL
Pit-1	NULL
and	NULL
Sp1	NULL
binding	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

2651	NULL
17189-17196	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

O-glycosylation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
:	NULL
implications	NULL
for	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Cell	NULL
.	NULL

55	NULL
:	NULL
125-133	NULL
.	NULL

6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL

